ghfus | 20809
            
            Myeloid fusion transcripts (NGS)
Keywords:
            
      ABL1
              ALK
              Acute leukaemia
              BCL2
              BRAF
              CCND1
              CREBBP
              EGFR
              ETV6
              FGFR1
              FGFR2
              FUS
              HMGA2
              JAK2
              KMT2A (MLL)
              MDS
              MECOM
              MET
              MLLT10
              MLLT3
              MYBL1
              MYH11
              Myelodisplastic syndrome
              Myelodysplastic neoplasms
              NTRK3
              NUP214
              Next-Generation Sequencing
              PDGFRA
              PDGFRB
              RARA
              RBM15
              RUNX1
              TCF3
              TFE3
              fusions
          Status
| Material | 
 | ||
|---|---|---|---|
| Hint | Fusionen mit den folgenden 29 Genen: ABL1, ALK, BCL2, BRAF, CCND1, CREBBP, EGFR, ETV6, FGFR1, FGFR2, FUS, HMGA2, JAK2, KMT2A (MLL), MECOM, MET, MLLT10, MLLT3, MYBL1, MYH11, NTRK3, NUP214, PDGFRA, PDGFRB, RARA, RBM15, RUNX1, TCF3, TFE3 | This analysis can be ordered by phone, after consultation with the consultation team, from bone marrow or asserved RNA. | There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. | Since in rare cases there may also be indications of hereditary changes, the GUMG (Federal Law on Genetic Testing in Humans) provides for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent). | ||
| Stability | Stability 1 day / 18-25°C; 4 days / 2-8°C | ||
| Duration | 5 days | ||
| Frequency | 2 x per week | ||
| Method | Next Generation Sequencing | 
Price/Rate
| Price | Price CHF 954.90 | 
|---|---|
| Rate | Rate 954.90 TP | 
 
   
   
   
  